GFM
IONS icon

GF Fund Management’s Ionis Pharmaceuticals IONS Stock Holding History

GF Fund Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$273K Buy
3,637
+454
+14% +$35.8K ﹤0.01% 260
2025
Q4 		$252K Sell
3,183
-246
-7% -$18.5K ﹤0.01% 275
2025
Q3 		$224K Sell
3,429
-613
-15% -$29.9K ﹤0.01% 276
2025
Q2 		$160K Hold
4,042
– – ﹤0.01% 337
2025
Q1 		$122K Buy
4,042
+727
+22% +$23.8K ﹤0.01% 349
2024
Q4 		$116K Buy
+3,315
New +$124K ﹤0.01% 321

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GF Fund Management's IONS Position: Q1 2026 in Review

GF Fund Management increased its Ionis Pharmaceuticals (IONS) stake by 14% in Q1 2026, buying an estimated $35.8K and bringing the position to 3,637 shares worth $273K. The position accounts for ﹤0.01% of the portfolio, ranked #260.

GF Fund Management first reported a position in IONS in Q4 2024 and has held it in 6 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • GF Fund Management held 3,637 shares of Ionis Pharmaceuticals worth $273K as of Q1 2026.
  • GF Fund Management bought 454 Ionis Pharmaceuticals shares in Q1 2026, an estimated $35.8K.
  • Ionis Pharmaceuticals made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #260 holding.
  • GF Fund Management first reported a position in Ionis Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.